Basal and Squamous Cell Carcinoma a review - PowerPoint PPT Presentation

1 / 47
About This Presentation
Title:

Basal and Squamous Cell Carcinoma a review

Description:

... SCC in regards to: Skin embryology and Anatomy. Epidemiology ... Embryology- ectodermal ... macrophages, mast cells, Langerhans cells, Merkel cells, ... – PowerPoint PPT presentation

Number of Views:260
Avg rating:3.0/5.0
Slides: 48
Provided by: treforn
Category:

less

Transcript and Presenter's Notes

Title: Basal and Squamous Cell Carcinoma a review


1
Basal and Squamous Cell Carcinoma - a review
  • Trefor Nodwell MDCM
  • Resident Division of Plastic Surgery
  • Dalhousie University

2
Overview
  • Address BCC and SCC in regards to
  • Skin embryology and Anatomy
  • Epidemiology
  • Pathophysiology and risk factors
  • Clinical presentation
  • Associated syndromes

3
Overview
  • Histopathology
  • Pre-malignant lesions
  • Management
  • Outcomes
  • Cases

4
Primary Skin Malignancies
  • Embryology-
  • ectodermal derivatives
  • epidermis, pilo-sebaceous and apocrine units
    eccrine sweat glands, nail units
  • Neuro-ectoderm
  • melanocytes, nerves, sensory receptors
  • Mesoderm
  • macrophages, mast cells, Langerhans cells, Merkel
    cells, fibroblasts, blood and lymph vessels, fat
    cells.

5
Primary Skin Malignancies
  • Anatomy
  • Epidermis
  • stratified squamous epithelium (keratinized)
  • four cell types- keratinocytes, melanocytes,
    Langerhans cells and Merkel cells
  • 0.04-1.4mm thick.

6
Primary Skin Malignancies
  • Dermis
  • Primarily acellular.
  • 15-40 times thicker than the epidermis
  • Upper thin papillary layer
  • Lower thicker reticular layer

7
Primary Skin Malignancies Epidemiology
  • 700-800 thousand cases in the US per annum
  • 1 of all cancer deaths
  • 77 BCC, 20 SCC, 3 melanoma and other
  • Incidence increasing 3-7 per year in the white
    population
  • Doubled between 1970-86

8
Primary Skin Malignancies
  • Pathophysiology
  • Etiologic factors
  • UV(B) exposure
  • Therapeutic (Ionizing) Radiation Exposure
  • Chemical Carcinogens
  • Viral Carcinogens
  • Multistep Hypothesis of Carcinogenesis
  • Initiation
  • Promotion
  • Progression

9
Primary Skin Malignancies
  • Biophysical Risk factors
  • Male
  • White (Celtic Origin)
  • Sunburn Easily
  • Increasing Age
  • Blue Eyes
  • Fair Complexion

10
Skin Phototypes
11
Basal Cell Carcinoma
12
Basal Cell Carcinoma
  • Most Common Malignancy of whites
  • Typically sporadic
  • Immature cells of the Basal Layer, External root
    sheath of the hair follicle.
  • No cellular anaplasia (a true carcinoma?)
  • Rare metastasis

13
Basal Cell Carcinoma - Subtypes
  • Nodular Ulcerative
  • Most common
  • Usually on the face
  • Small, slow growing
  • Firm
  • Telangectasias
  • Ulceration

14
Basal Cell Carcinoma - Subtypes
  • Superficial
  • Single or multiple patches
  • Trunk
  • Indurated scaly
  • Differential - eczema, psoriasis or tinea.

15
Basal Cell Carcinoma - Subtypes
  • Sclerosing (Morpheaform)
  • Yellow white plaques
  • Ill defined boarders
  • Most aggressive
  • Most likely to recur
  • Central sclerosis and scarring

16
Basal Cell Carcinoma - Subtypes
  • Pigmented
  • Similar to nodular type
  • Deep brown pigmentation
  • Differential- malignant melanoma

17
Basal Cell Carcinoma - Subtypes
  • Fibroepithelioma
  • Pinkus Tumour
  • Raised
  • Moderately firm
  • Erythematous and smooth
  • Lower trunk (lumbosacral area)_

18
Basal Cell Carcinoma - Syndromes
  • Basal Cell Nevus (Gorlins) Syndrome
  • Autosomal Dominant, no sex linkage, low
    penetrance
  • ? Mutated tumour suppressor at Ch 9q23.1-q31
  • Childhood onset
  • BCC (average age 20y)
  • Pitting of palms and soles

19
Basal Cell Carcinoma - Syndromes
  • Basal Cell Nevus (Gorlins) Syndrome
  • odontogenic keratocysts (epithelial jawline
    cysts)
  • CNS calcifications (dura), mental retardation

20
Basal Cell Carcinoma - Syndromes
  • Bazex Syndrome
  • AD
  • Adolescence
  • Multiple facial BCC
  • Ice pick marks
  • Hair abnormalities
  • Foregut Neoplasms
  • Possible responsiveness to Retinoic acid.

21
Basal Cell Carcinoma - Syndromes
  • Rombo Syndrome
  • Autosomal Dominant
  • Manifestation gt35 y
  • Atrophoderma Vermiculatum
  • Milia
  • Peri follicualr pitting
  • Scarring alopecia
  • Peripheral vasodilation and cyanosis

22
Other Associated Syndromes
  • Xeroderma pigmentosum
  • Incomplete sex-linked recessive
  • Deficiency of endonuclease
  • Childhood onset
  • Extreme sun sensitivity
  • BCC,SCC,Melanoma

23
Other Associated Syndromes
  • Albinism
  • Genetic abnormality of the pigment system.

24
Other Associated Syndromes
  • Nevus Sebaceous of Jadassohn
  • Usually sporadic
  • Solitary patch/plaque
  • Scalp
  • Yellow-brown
  • Present at birth/early childhood

25
Basal Cell Carcinoma - Histopathology
  • Resemble normal basal cells
  • Hyperchromatic nuclei, scant cytoplasm
  • Clustered separate from stroma
  • Peripheral palisading
  • Desmoplastic reaction
  • Nests or in continuity

26
Squamous Cell Carcinoma
27
Squamous Cell Carcinoma
  • Originates from spindle cell layer
  • Older men sun exposed skin
  • Sharply defined, erythematous plaque
  • Elevated border

28
Squamous Cell Carcinoma
  • Painless firm nodule, scaling and horn formation
  • Verrucous variant - fungating, slow growing,
    deeply invasive, less metastasis

29
Squamous Cell Carcinoma
  • Etiologic Factors
  • Sun exposure
  • Chronic ulceration (osteomyelitis, burn wounds)
  • Cytotoxic agents, immunosuppressives
  • Discoid Lupus
  • Hydradenitis suppurativa
  • Smoking, tobacco and Betel nut chewing

30
Squamous Cell Carcinoma
  • Histopathology
  • Atypical cells replacing dermis
  • Pleomorphic, multiple mitotic figures
  • Migration through basement membrane
  • Horn pearls
  • Graded from well to poorly differentiated

31
Squamous Cell Carcinoma Precursor Lesions
  • Actinic (Solar) Keratosis
  • Rough, scaly
  • Erythematous plaques
  • Forehead, nose, cheeks, pinna
  • Multiple
  • 25 Regress
  • 11000 convert per year

32
Squamous Cell Carcinoma Precursor Lesions
  • Bowens Disease
  • Older men
  • Carcinoma in situ of skin or mucous membranes
  • Mostly solitary
  • Sharply defined.
  • Dull scaly plaque
  • Indolent history

33
Squamous Cell Carcinoma Precursor Lesions
  • Keratoacnathoma
  • Rapid initial growth
  • Latent period
  • Fleshy, elevated, nodular
  • Possible regression
  • Grossly and microscopically resemble SCC
  • Excision recommended

34
Squamous Cell Carcinoma Precursor Lesions
  • Leukoplakia
  • Oral, vulvar, vaginal mucosa
  • Smoking history
  • Ill fitting dentures
  • Elevated, sharply defined, patchy keratinization

35
BCC and SCC- Approach to Treatment
  • Surgical Excision
  • Simple, versatile, fast
  • Elliptical excision and primary closure
    applicable to 80 of BCC,SCC
  • Large questionable lesions - biopsy
  • ? - Delayed closure (awaiting pathology)
  • Skin grafts, composite grafts, local flaps.
  • Optimal surgical margin unknown

36
Planning Margins for Primary excision BCC
37
BCC and SCC- Approach to Treatment
  • Mohs (Micrographic) Surgery
  • Frederic Mohs, 1941
  • Frozen Section
  • Examine margins in three dimensions
  • Medial canthus, alar regions

38
BCC and SCC- Approach to Treatment
  • Laser Excision
  • CO2 laser
  • Focused mode -coagulate and excise tissue
  • Unfocused mode - vaporize small tumours.
  • May hinder microscopic evaluation
  • May damage the recipient bed for a graft.

39
BCC and SCC- Approach to Treatment
  • Non-Operative
  • Radiation for BCC (4000-6000 cGy, 10-30
    fractions)
  • older infirm patients
  • difficult areas
  • Complications dry eye, lacrimal duct scarring,
    skin necrosis
  • Draw backs - no margins, multiple visits.

40
BCC and SCC- Approach to Treatment
  • Non -Operative
  • Chemotherapy (5FU)
  • hydrophilic base 5-20 concentration
  • applied at night and covered
  • 4-12 weeks
  • Diffuse,Superficial Lesions, 5-20 mm.
  • Heals over 1-2 months

41
BCC and SCC- Approach to Treatment
  • Non-Operative
  • Isotretinoin
  • in vivo antineoplastic effects, promoting
    cellular differentiation
  • topical form only
  • Interferon alpha
  • nonspecific activation of macrophages and Natural
    Killer Cells.

42
BCC and SCC- Approach to Treatment
  • Non Operative
  • Photo therapy
  • Inactive agent administered
  • Accumulates in tissue of interest
  • Activated by LASER light.
  • Cryosurgery
  • Small nodular ulcerative, well-defined
  • 5-15mm, wound contraction acceptable
  • Liquid N2 (-195.6 C) used to reach intracellular
    temp of -40 C.

43
BCC and SCC- Outcomes
  • Risk Factors for Recurrence
  • Long Duration
  • High-risk area
  • Large size
  • Aggressive subtype
  • Neglected
  • Recurrent
  • Radiation exposure

44
BCC and SCC- Outcomes
  • Acceptable goal
  • Surgical excision
  • Evaluation of margins
  • Re-excision of involved margins
  • Yields 95 cure rate for primary tumours

45
BCC and SCC- Outcomes
  • The Positive Margin
  • Microscopic re-excise wound scar
  • Observe Recurrence typically within 2 years,
    30.
  • ? increased risk for deep and lateral margins
  • Grossly Recurrent tumour re-excise wide margins.
    Poor cosmetic result

46
Primary Skin Malignancies
  • Common
  • Increasing incidence
  • High cure rates
  • High patient-surgeon satisfaction.
  • Can be a technical challenge
  • Still many unanswered questions ...

47
The Cases
Write a Comment
User Comments (0)
About PowerShow.com